Lataa...

JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate

Clinical significance of the JAK2V617F mutation in patients with a myeloproliferative neoplasm has been the target of intensive research in recent years. However, there is considerably uncertainty about prognosis in JAK2V617F positive individuals without overt signs of myeloproliferative disease. In...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Haematologica
Päätekijät: Nielsen, Camilla, Bojesen, Stig E., Nordestgaard, Børge G., Kofoed, Klaus F., Birgens, Henrik S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Ferrata Storti Foundation 2014
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4562533/
https://ncbi.nlm.nih.gov/pubmed/24907356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.107631
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!